Top Markets
Coin of the day
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Peringkat dalam Saham #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Harga Saham
$0.003
Terakhir disinkronkan: 2025-12-12
Kapitalisasi Pasar
$343.91K
Perubahan (1 hari)
-16.67%
Perubahan (1 tahun)
-90.23%
Negara
US
Perdagangan Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Kategori

Riwayat harga saham Reviva Pharmaceuticals Holdings, Inc. (RVPHW)
Harga penutupan tertinggi: $0.01 pada 2025-12-01

Harga penutupan terendah: $0.33 pada 2018-10-01
Riwayat harga saham Reviva Pharmaceuticals Holdings, Inc. dari 2018 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 305.88%
2025 -96.70%
2024 -75.67%
2023 0.82%
2022 134.68%
2021 -39.09%
2020 167.36%
2019 -15.00%
2018 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$517.18 32.51%
US
$857.76 31.47%
NL
$745.22 9.11%
CH
$1.07K -6.40%
KR
$258.46 14.18%
BE